Mark Chin - Jun 23, 2022 Form 4 Insider Report for Iterum Therapeutics plc (ITRM)

Role
Director
Signature
/s/ Mark Chin
Stock symbol
ITRM
Transactions as of
Jun 23, 2022
Transactions value $
$0
Form type
4
Date filed
6/24/2022, 06:00 PM
Previous filing
Jun 24, 2022
Next filing
Jan 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ITRM Ordinary Shares Options Exercise +36.8K 36.8K Jun 23, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITRM Restricted Share Units Options Exercise $0 -36.8K -100% $0.00* 0 Jun 23, 2022 Ordinary Shares 36.8K $0.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted share units ("RSUs") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs.
F2 On June 23, 2021, the reporting person was granted an award of 36,798 RSUs, which vested on June 23, 2022.